Bacillus megaterium CYP102A1 oxidation of acyl homoserine lactones and acyl homoserines

被引:114
作者
Chowdhary, Puneet K. [1 ]
Keshavan, Neela [2 ]
Nguyen, Hien Q. [1 ]
Peterson, Julian A. [3 ]
Gonzalez, Juan E. [2 ]
Haines, Donovan C. [1 ]
机构
[1] Univ Texas Dallas, Dept Chem, Richardson, TX 75083 USA
[2] Univ Texas Dallas, Dept Mol & Cell Biol, Richardson, TX 75080 USA
[3] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA
关键词
D O I
10.1021/bi701945j
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Quorum sensing, the ability of bacteria to sense their own population density through the synthesis and detection of small molecule signals, has received a great deal of attention in recent years. Acyl homoserine lactones (AHLs) are a major class of quorum sensing signaling molecules. In nature, some bacteria that do not synthesize AHLs themselves have developed the ability to degrade these compounds by cleaving the amide bond or the lactone ring. By inactivating this signal used by competing bacteria, the degrading microbe is believed to gain a competitive advantage. In this work we report that CYP102A1, a widely studied cytochrome P450 from Bacillus megaterium, is capable of very efficient oxidation of AHLs and their lactonolysis products acyl homoserines. The previously known substrates for this enzyme, fatty acids, can also be formed in nature by hydrolysis of the amide of AHLs, so CYP102A1 is capable of inactivating the active parent compound and the products of both known pathways for AHL inactivation observed in nature. AHL oxidation primarily takes place at the omega-1, omega-2, and omega-3 carbons of the acyl chain, similar to this enzyme's well-known activity on fatty acids. Acyl homoserines and their lactones are better substrates for CYP102A1 than fatty acids. Bioassay of the quorum sensing activity of oxidation products reveals that the subterminally hydroxylated AHLs exhibit quorum sensing activity, but are 18-fold less active than the parent compound. In vivo, B. megaterium inactivates AHLs by a CYP102A1 dependent mechanism that must involve additional components that further sequester or metabolize the products, eliminating their quorum sensing activity. Cytochrome P450 oxidation of AHLs represents an important new mechanism of quorum quenching.
引用
收藏
页码:14429 / 14437
页数:9
相关论文
共 47 条
  • [1] BODDUPALLI SS, 1990, J BIOL CHEM, V265, P4233
  • [2] BODDUPALLI SS, 1992, J BIOL CHEM, V267, P10375
  • [3] The highly stereoselective oxidation of polyunsaturated fatty acids by cytochrome P450BM-3
    Capdevila, JH
    Wei, SZ
    Helvig, C
    Falck, JR
    Belosludtsev, Y
    Truan, G
    GrahamLorence, SE
    Peterson, JA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (37) : 22663 - 22671
  • [4] Insecticidal Bacillus thuringiensis silences Erwinia carotovora virulence by a new form of microbial antagonism, signal interference
    Dong, YH
    Zhang, XF
    Xu, JL
    Zhang, LH
    [J]. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2004, 70 (02) : 954 - 960
  • [5] Identification of quorum-quenching N-acyl homoserine lactonases from Bacillus species
    Dong, YH
    Gusti, AR
    Zhang, Q
    Xu, JL
    Zhang, LH
    [J]. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2002, 68 (04) : 1754 - 1759
  • [6] Quenching quorum-sensing-dependent bacterial infection by an N-acyl homoserine lactonase
    Dong, YH
    Wang, LH
    Xu, JL
    Zhang, HB
    Zhang, XF
    Zhang, LH
    [J]. NATURE, 2001, 411 (6839) : 813 - 817
  • [7] Fatty acid signals in Bacillus megaterium are attenuated by cytochrome P-450-mediated hydroxylation
    English, N
    Palmer, CNA
    Alworth, WL
    Kang, L
    Hughes, V
    Wolf, CR
    [J]. BIOCHEMICAL JOURNAL, 1997, 327 : 363 - 368
  • [8] Induction of cytochrome P-450(BM-3) (CYP 102) by non-steroidal anti-inflammatory drugs in Bacillus megaterium
    English, N
    Hughes, V
    Wolf, GR
    [J]. BIOCHEMICAL JOURNAL, 1996, 316 : 279 - 283
  • [9] Antioxidant-mediated attenuation of the induction of cytochrome P450BM-3(CYP102) by ibuprofen in Bacillus megaterium ATCC 14581
    English, NT
    Rankin, LC
    [J]. BIOCHEMICAL PHARMACOLOGY, 1997, 54 (04) : 443 - 450
  • [10] FULCO AJ, 1991, ANNU REV PHARMACOL, V31, P177